Back

Corrigendum to: PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages

Cardiovascular Research

14 December 2021
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Inclisiran reduces expression of Toll-like receptor-4 on circulating monocytes
28 August 2023
thumbnail
Congress Presentation
Comparing coronary artery plaque regression in patients treated with ezetimibe or PCSK9 inhibitors following acute coronary syndrome: a systematic review and meta-analysis
29 August 2025
thumbnail
Congress Presentation
Effectiveness of PCSK9 inhibitors in homozygous familial hypercholesterolemia: insights from a Saudi Arabia genetic population
3 April 2025
thumbnail
Congress Presentation
Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources